Attached files

file filename
EX-99.1 - PRESS RELEASE - Innophos Holdings, Inc.golowski-treinenpr.htm

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

 

 

FORM 8-K
CURRENT REPORT

 

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 

Date of report (Date of earliest event reported:  March 30, 2010)

 

 

 

Innophos Holdings, Inc.
(Exact name of Registrant as specified in its their Charter)

 

 

Delaware
(States or other jurisdictions of incorporation)

001-33124
(Commission File Numbers)

20-1380758
(IRS Employer Identification Nos.)

 

 

259 Prospect Plains Road
Cranbury, New Jersey 08512
(Address of Principal Executive Office, including  Zip Code)

 

 

(609) 495-2495
(Registrant’s Telephone Number, Including Area Code)

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 


 

Item 5.02   Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

On March 30, 2010, the Registrant issued a press release announcing the resignation, effective April 1, 2010, of Timothy Treinen as Vice President, Prosphate Business, and Mr. Treinen’s continued service as Special Projects Leader, pending his retirement at year end. The release also announced that Joseph Golowski, currently serving as Vice President, Sales, had been appointed to the newly created position of Vice President, Specialty Phosphates Business.

 

A copy of the release is filed as Exhibit 99.1 to this Current Report on Form 8-K.

 

 

Item 9.01 Financial Statements and Exhibits.

 

 

 

(d) Exhibit No. 

Description 

 

 

        99.1 

Registrant’s press release dated March 30, 2010

 

 

 

 

 

SIGNATURES

According to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on their behalf by the undersigned, hereunto duly authorized.

 

INNOPHOS HOLDINGS, INC.

 

 

 

By:          /s/ Neil Salmon

 

Name:     Neil Salmon
Title:       Vice President and Chief Financial Officer

Dated: March 30, 2010